Dajun Yang
- Oncology top 1%
- Cancer-related Molecular Pathways 29
- Toxicology top 1%
- Cancer Research top 2%
- Molecular Biology top 2%
- Cell death mechanisms and regulation 29
- Ubiquitin and proteasome pathways 18
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 23
-
- Chronic Myeloid Leukemia Treatments 18
- Acute Myeloid Leukemia Research 13
-
- Cancer Mechanisms and Therapy 16
-
- Gastric Cancer Management and Outcomes 13
- Co-authors
- Shaomeng WangMiao‐Zhen QiuRibo GuoPeter P. RollerManchao ZhangRui‐Hua XuZaneta Nikolovska‐ColeskaYifan Zhai
- Cited by
- OncologyToxicologyCancer Research
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Dajun Yang
185 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 2.0k
- Toxicology 191
- Cancer Research 810
- Molecular Biology 3.5k
- Genetics 295
Countries citing papers authored by Dajun Yang
This map shows the geographic impact of Dajun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dajun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dajun Yang more than expected).
Fields of papers citing papers by Dajun Yang
This network shows the impact of papers produced by Dajun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dajun Yang. The network helps show where Dajun Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dajun Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 37 | |
| 10 | 2022 | 6 | |
| 11 | Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors. | 2015 | 85 |
| 12 | Increased WNT6 expression in tumor cells predicts unfavorable survival in esophageal squamous cell carcinoma patients. | 2015 | 14 |
| 13 | 2013 | 34 | |
| 14 | 2011 | 12 | |
| 15 | 2008 | 27 | |
| 16 | In vivo efficacy of AT-101, an orally active pan Bcl-2 family protein inhibitor in combination with docetaxel or erlotinib for non small cell lung cancer therapy | 2007 | 1 |
| 17 | 2005 | 12 | |
| 18 | Gossypol(-), a potent small molecule inhibitor of Bcl-2/xl, improves response to radiation therapy and results in tumor regression of human prostate cancer | 2004 | 1 |
| 19 | Analysis of Theorem-proving Aiding Tool──PVS | 2000 | 0 |
| 20 | Pyripyropenes, Novel ACAT Inhibitors Produced by Aspergillus fumigatus. IV. Structure Elucidation of Pyripyropenes M to R.:IV. Structure Elucidation of Pyripyropenes M to R | 1996 | 23 |
About Dajun Yang
Dajun Yang is a scholar working on Oncology, Hematology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 194 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (29 papers), Cell death mechanisms and regulation (29 papers), Chronic Lymphocytic Leukemia Research (23 papers), Ubiquitin and proteasome pathways (18 papers), Chronic Myeloid Leukemia Treatments (18 papers), Cancer Mechanisms and Therapy (16 papers), Gastric Cancer Management and Outcomes (13 papers) and Acute Myeloid Leukemia Research (13 papers). The work is most often cited by research in Oncology (2.0k citations), Toxicology (191 citations), Cancer Research (810 citations), Molecular Biology (3.5k citations) and Genetics (295 citations). Dajun Yang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shaomeng Wang, Miao‐Zhen Qiu, Ribo Guo, Peter P. Roller, Manchao Zhang, Rui‐Hua Xu, Zaneta Nikolovska‐Coleska, Yifan Zhai, York Tomita and Terrence R. Burke. Their work appears in journals such as Cancer Research, Blood, Journal of Clinical Oncology, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.